Inkef

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

Salvia BioElectronics B.V., founded in 2017 and headquartered in Eindhoven, the Netherlands, focuses on developing bioelectronic therapies for individuals with chronic neurological conditions, particularly chronic migraines. Drawing its name from the Latin word for "to stay healthy," Salvia is committed to providing drug-free, effective, and side-effect-free solutions. The company leverages a team of experienced professionals, including entrepreneurs, engineers, and scientists, who have extensive backgrounds in the medical device industry. Salvia aims to make its innovative bioelectronic solutions widely accessible, addressing the needs of patients seeking alternative treatments for their conditions.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Cashforce BV operates a sophisticated cash flow management and forecasting platform designed to enhance financial efficiency for businesses. Founded in 2013 and based in Antwerp, Belgium, with additional offices in New York, Amsterdam, Copenhagen, and London, the company serves various sectors, including wholesale and distribution, transportation, logistics, and manufacturing. Its platform offers users the ability to forecast cash flows across multiple companies, bank accounts, and currencies, allowing for early detection of potential cash shortages or surpluses. Cashforce distinguishes itself through seamless integration with various ERP and banking systems, enabling detailed transaction-level analysis. The platform also features an AI-based simulation engine that supports multiple cash flow scenarios and impact assessments, providing cash visibility to multinational corporations in over 120 countries. The company has formed a strategic alliance with Treasury Intelligence Solutions GmbH to further enhance its offerings.

Blendle is a digital media platform that allows readers to purchase articles from various Dutch and Belgian newspapers and magazines, including prominent publications like the Economist. Users can buy individual articles for prices ranging from €0.10 to €0.30, and they are presented with a selection of recommendations similar to social media feeds. New users are provided with an initial credit of €2.50 to explore the platform. The service includes a brief refund window for article purchases, after which Blendle retains a 30% commission on sales. By offering a pay-per-article model, Blendle aims to enhance access to quality journalism and cater to readers' preferences through personalized recommendations.

Bloomon B.V., founded in 2014 and headquartered in Amsterdam, Netherlands, operates an online retail platform specializing in flower delivery across Europe. The company emphasizes a direct-to-consumer model, sourcing flowers directly from growers to ensure quality. Bloomon offers a subscription service allowing customers to conveniently arrange their orders online, with the flexibility to pause, change, or cancel deliveries without any commitment. This approach enables users to create customized packaging with fresh flowers, enhancing their overall experience. Focused on client satisfaction and product quality, Bloomon prioritizes service over competition in the online flower market.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

InteRNA Technologies B.V. is a biotechnology company focused on the development of microRNA (miRNA)-based therapeutics for cancer treatment. The company's innovative approach leverages the unique properties of miRNAs to target previously undruggable pathways involved in cancer initiation, progression, and metastasis. By utilizing advanced techniques such as massively parallel sequencing and proprietary bioinformatics, InteRNA analyzes and validates miRNA sequences to enhance drug efficacy and reduce resistance to existing therapies. Founded in 2006, the company operates from Nijmegen, the Netherlands, and has a dedicated research and development center in Utrecht. Recently, InteRNA has secured additional equity financing to advance its lead program for melanoma treatment, demonstrating its commitment to developing novel solutions in oncology.

Audion Therapeutics BV is a biopharmaceutical company based in Amsterdam, Netherlands, focused on the discovery, development, and commercialization of therapies for ear-related diseases, particularly hearing loss. Founded in 2008, the company is engaged in small molecule drug discovery aimed at regenerating inner hair cells, which are vital for hearing. Audion Therapeutics leverages a unique approach by targeting a protein complex known as gamma-secretase to address sensorineural hearing loss, often associated with aging. The company's intellectual property portfolio comprises new drug molecules, advanced delivery systems, and innovative tools for research in hearing and hearing loss.

Bloomon B.V., founded in 2014 and headquartered in Amsterdam, Netherlands, operates an online retail platform specializing in flower delivery across Europe. The company emphasizes a direct-to-consumer model, sourcing flowers directly from growers to ensure quality. Bloomon offers a subscription service allowing customers to conveniently arrange their orders online, with the flexibility to pause, change, or cancel deliveries without any commitment. This approach enables users to create customized packaging with fresh flowers, enhancing their overall experience. Focused on client satisfaction and product quality, Bloomon prioritizes service over competition in the online flower market.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, the company aims to enhance patient comfort and therapeutic outcomes with its innovative, high-resolution, and MRI-compatible DBS system. Sapiens specializes in developing a comprehensive DBS solution that includes navigation and steering software, as well as implants specifically designed for patients with Parkinson's disease. With offices in Eindhoven, the Netherlands, and Munich, Germany, Sapiens leverages patented technologies to deliver effective and precise treatment options for individuals suffering from this neurological condition.

Lanthio Pharma B.V. is a biopharmaceutical company based in Groningen, the Netherlands, specializing in the discovery and development of lantipeptide drugs aimed at treating conditions such as fibrosis, stroke, heart failure, and multiple sclerosis. The company employs its proprietary lanthionine-peptide drug discovery technology, LanthioPep™, to create novel peptide therapeutics that exhibit enhanced resistance to peptidase degradation and high receptor specificity. Among its product pipeline are LP2, designed to target fibrosis; PanCyte, intended for ischemic stroke recovery and related conditions; a Lanthi-apelin agonist for various organ systems; and Lanthi-galanin for multiple sclerosis. Founded in 2010, Lanthio Pharma operates as a subsidiary of Morphosys AG, focusing on generating stable, peptidase-resistant peptides that possess high intrinsic activity for several G-protein-coupled receptor targets.

Robin Radar Systems B.V., based in The Hague, the Netherlands, specializes in developing radar systems for bird detection and tracking. The company offers several products, including a 2D Mobile system that detects bird presence, number, location, direction, speed, and route over distances of up to 20 kilometers; a 3D Fixed system that provides similar data up to 10 kilometers; and a 3D Flex system that combines horizontal S-band radar with flexible frequency modulated continuous wave radar. Their Military XL system is designed to assist air forces in preventing bird strikes. Robin Radar Systems also offers essential support services such as testing, training, documentation, and maintenance. Established in 2010 as a spin-off from the Dutch Research Institute for Applied Science (TNO), the company has access to advanced radar technology developed for bird tracking since the 1970s. Their innovative solutions aim to enhance safety and sustainability for wind farms, airports, and other operations while minimizing environmental impacts.

Salvia BioElectronics B.V., founded in 2017 and headquartered in Eindhoven, the Netherlands, focuses on developing bioelectronic therapies for individuals with chronic neurological conditions, particularly chronic migraines. Drawing its name from the Latin word for "to stay healthy," Salvia is committed to providing drug-free, effective, and side-effect-free solutions. The company leverages a team of experienced professionals, including entrepreneurs, engineers, and scientists, who have extensive backgrounds in the medical device industry. Salvia aims to make its innovative bioelectronic solutions widely accessible, addressing the needs of patients seeking alternative treatments for their conditions.